Side effects of hormonal therapy for breast cancer
Hormonal therapy is an integral part of breast cancer treatment for women with hormone receptor-positive breast cancer. Hormone receptor-positive tumors have receptors for estrogen and/or progesterone present on the cancer cells. Hormonal therapy blocks or reduces the production of estrogen or progesterone, slowing or halting the growth of hormone receptor-positive breast cancer cells. The most commonly used hormonal therapy drugs include tamoxifen, aromatase inhibitors (AIs), and ovarian suppression medications (OSMs). While hormonal therapy is effective in reducing recurrence of breast cancer and extending survival, it can also have side effects that can be troubling for many women.
Tamoxifen
Tamoxifen, an oral hormonal therapy medication, works by blocking the action of estrogen on hormone receptor-positive breast cancer cells. It is typically prescribed for women with early-stage breast cancer and for those at high risk of developing breast cancer. Tamoxifen may cause some women to experience hot flashes, mood changes, vaginal dryness, and occasional nausea. It can also cause more serious side effects such as blood clots, stroke, and uterine cancer. Women taking tamoxifen should be monitored closely for these side effects.
Aromatase inhibitors
Aromatase inhibitors (AIs) are a group of hormonal therapy drugs that work by blocking the production of estrogen in postmenopausal women. They are used after surgery and radiation for breast cancer in women with estrogen receptor-positive tumors. Some commonly used AIs include anastrozole, letrozole, and exemestane. AIs can cause joint pain, stiffness, and bone thinning (osteoporosis). Other side effects may include hot flashes, vaginal dryness, and fatigue. Women taking AIs should have regular bone density tests and discuss any possible side effects with their healthcare provider.
Ovarian suppression medications
Ovarian suppression medications (OSMs) are used to block the production of estrogen in pre-menopausal women with breast cancer. These medications work by inhibiting the function of the ovaries, which produce estrogen and progesterone. Two commonly used OSMs include goserelin and leuprolide. Like tamoxifen and AIs, OSMs can cause hot flashes, fatigue, and nausea. In addition, they can cause temporary bone thinning and decrease in sexual desire. Women taking OSMs should be monitored for any side effects and have regular bone density tests.
Managing side effects
While hormonal therapy can have side effects, most women are able to tolerate these medications without major disruption to their daily lives. Some women may find that side effects interfere with their quality of life, and others may experience more serious or persistent symptoms that require intervention. It is important for women undergoing hormonal therapy to discuss any side effects with their healthcare provider and work together to manage any troublesome symptoms.
There are several strategies that can help manage side effects of hormonal therapy. Lifestyle modifications such as regular exercise, diet modifications, and stress reduction techniques can help alleviate symptoms. Medications such as antidepressants, gabapentin, or clonidine can be prescribed to help manage hot flashes. Other medications can be prescribed to address specific side effects such as osteoporosis.
Conclusion
Hormonal therapy is an important and effective treatment option for women with hormone receptor-positive breast cancer. While it can have side effects, most women are able to manage these symptoms and tolerate these medications without major interruption to their lives. By discussing any side effects with their healthcare provider and employing strategies for symptom relief, women can continue to receive hormonal therapy and maximize its cancer-fighting potential. If you or someone you know is undergoing hormonal therapy for breast cancer, it is important to be informed about potential side effects and receive support for managing symptoms.